Cannabis Law Report

SEPTEMBER 20, 2021

Embark is also the majority owner of ProteinQuest, which applies Embark’s innovative and proprietary technology to the protein-enhanced and functional food industries with initial commercial products utilizing hemp seed, positioning it for further growth in the health and wellness industry.

Hash 52

Hash Seed-To-Sale Research and Development Topical 52

SpeedWeed

JULY 29, 2021

Colombia President Ivan Duque signed a decree ending “the ban on the export of dried flower” in an event organized at a facility owned by Clever Leaves, one of the 18 multinationals that grows medicinal cannabis in Colombia. National and international companies have invested US$250mn in Colombia to develop this industry.

Media 52

Media Business Law Seed-To-Sale 52

Project CBD

FEBRUARY 28, 2023

HerbalGram, the acclaimed quarterly journal of the American Botanical Council, recently published its 2021 “Herb Market Report,” which included data on sales of CBD as an herbal ingredient in mainstream and natural retail channels in the United States. E-commerce sales of CBD in the U.S. increase in annual sales.

CBD 144

CBD Seed-To-Sale Food Access 144

SMPL

MAY 26, 2020

Ringo said he would sell his seeds for as little as $5.). They sat in a circle at a house in the hills a few hours north of San Francisco — where wine country becomes weed country — to discuss the therapeutic potential of CBD, and how to get people to take it seriously.

CBD 40

CBD Research and Development Pharmaceutical Seed-To-Sale 40

Cannabis Law Report

DECEMBER 2, 2021

Canndoc, a wholly owned subsidiary of InterCure, is Israel’s largest licensed cannabis producer and one of the first to offer Good Manufacturing Practices (GMP) certified and pharmaceutical-grade medical cannabis products. Cookies Partners With Leading Global Cannabis Company InterCure to Open Retail Locations in Austria and the U.K.

Supply Chain 52

Supply Chain Seed-To-Sale Media Events 52

Cannabis Law Report

MARCH 29, 2020

At an HIV Community Cannabis Education event held in Toronto, a cannabis company proudly declared their company had not had a single product recall to date. o Medical conditions: A panel of doctors must be present at the time of any product research to ensure no adverse effects lessen or damage the health of participants.

Compliance 69

Compliance Compliance Supply Chain Research and Development 69

Veriheal

JULY 28, 2021

The bill, which was approved by the majority of judiciary committee members, would develop a patient, manufacturing, licensing, and sales system for the plant’s use. In the event of SB 711 being adopted by lawmakers, the list of qualifying conditions could be expanded by a 13-member Medical Cannabis Advisory Board. .

Seed-To-Sale 59

Seed-To-Sale Research and Development Pharmaceutical Conditions 59

Cannabis Law Report

NOVEMBER 9, 2021

Experienced Cannabis Executive, Registered Pharmacist and European Patent Attorney to Lead Pharmaceutical Strategy & Operations, Corporate Quality Management, Legal & Regulatory Affairs. She will work closely with Akanda’s EU GMP processing and distribution partner Cantourage GmbH, based in Germany. . About Akanda Corp.

Pharmaceutical 52

Pharmaceutical Seed-To-Sale Supply Chain Events 52

Cannabis Law Report

NOVEMBER 17, 2021

This financing provides vital capital to accelerate our plans to build one of the leading international medical cannabis companies with a unique seed-to-patient business model,” said Tej Virk, CEO and Director of Akanda. “In And we’re establishing a world class team.

Seed-To-Sale 52

Seed-To-Sale Supply Chain Cultivation Events 52

Cannabis Law Report

NOVEMBER 17, 2021

This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such jurisdiction.

Seed-To-Sale 52

Seed-To-Sale Supply Chain Cultivation Events 52

Cannabis Law Report

JUNE 4, 2021

They write… As the global COVID-19 pandemic drags on around the world, the damaging effects to mental health are becoming more and more apparent. With a 25% increase in suicide rates in young adults and over 50% of all adults reporting some type of mental health issue (depression, anxiety, stress, etc.), Source: [link].

Research and Development 51

Research and Development Medicine Treatment Pharmaceutical 51

Cannabis Law Report

OCTOBER 17, 2019

As more countries legalize or decriminalize the cultivation, manufacture, sale, and use of cannabis, companies across a variety of industries are looking for opportunities to capitalize on this emerging market. Selinger cites software, point-of-sale systems, and packaging as areas that are thriving in the state.

Law 40

Law Seed-To-Sale Hemp Recreational 40